Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity

[Image: see text] We report the development and characterization of compound 22 (MK-5046), a potent, selective small molecule agonist of BRS-3 (bombesin receptor subtype-3). In pharmacological testing using diet-induced obese mice, compound 22 caused mechanism-based, dose-dependent reductions in foo...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Sebhat, Iyassu K., Franklin, Christopher, Lo, Michael M.-C., Chen, David, Jewell, James P., Miller, Randy, Pang, Jianmei, Palyha, Oksana, Kan, Yanqing, Kelly, Theresa M., Guan, Xiao-Ming, Marsh, Donald J., Kosinski, Jennifer A., Metzger, Joseph M., Lyons, Kathryn, Dragovic, Jasminka, Guzzo, Peter R., Henderson, Alan J., Reitman, Marc L., Nargund, Ravi P., Wyvratt, Matthew J., Lin, Linus S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Chemical Society 2010
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4018145/
https://ncbi.nlm.nih.gov/pubmed/24900253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml100196d
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi